Life Sciences Sector

There are various themes running in the Life Sciences sector globally:

Companies and local governments, particularly those in developing countries, are being forced to look at alternative measures to contain fast moving diseases. Zika and Ebola, for example, placed a huge strain on local health and social care systems.

The number of worldwide Dementia sufferers is set to double every 20 years, meaning that by 2030 there will be around 74.7 million sufferers. Technology such as Virtual Reality may be used to treat the condition, though refinement is still needed.

New technologies, as well as improvements on older technologies, mean that healthcare companies are having to adapt quickly to avoid being overtaken by new market entrants. For example, Virtual Reality has been touted as an answer to some mental disorders where drugs were previously the given treatment. Similarly, improved 3D printed prosthetics are widening the scope for both surgeons and consumers as more refined methods of production are utilized. Some commentators, however, are saying that wearable technology has ‘had its day’, and has a limited future in healthcare.

Under the Life Sciences Sector, we serve the below sub-sectors:

  • Health
  • Medtech
  • Pharmaceuticals
  • Clinics & Hospitals
  • Laboratories
  • Medical Devices

Selected Completed Transactions

For more information